RAFFA WEALTH MANAGEMENT, LLC’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
CFM
BC
LSERS
SOADOR
ETC
QCM
PFSRSONJ
RG
RAFFA WEALTH MANAGEMENT, LLC's PTCT Position: Q2 2026 in Review
RAFFA WEALTH MANAGEMENT, LLC held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 11 shares worth $897. The position accounts for ﹤0.01% of the portfolio, ranked #1052.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in PTCT in Q1 2020 and has held it in 26 quarters since. The position peaked at $900 in Q1 2021. 73 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC held 11 shares of PTC Therapeutics worth $897 as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC left its PTC Therapeutics share count unchanged in Q2 2026.
- PTC Therapeutics made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #1052 holding.
- RAFFA WEALTH MANAGEMENT, LLC first reported a position in PTC Therapeutics in Q1 2020 and has held it in 26 quarters since.
- RAFFA WEALTH MANAGEMENT, LLC's PTC Therapeutics position peaked at $900 in Q1 2021.
- 73 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.